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The Authors reply:
“Dual energy X-ray absorptiometry: gold standard for
muscle mass?” by Scafoglieri et al.
Weappreciate your interest in our recent publication1 and your
valuable comments. We completely agree that there is still am-
biguity in the literature on the deﬁnition and use of parameters
characterizing body composition.2 From this perspective, DXA
actually is a progress as the deﬁnition of lean and fat (according
to DXA terminology) and based on differences of X-ray mass
absorption coefﬁcients. With a two energy X-ray system, two
materials that differ in atomic number can be uniquely identi-
ﬁed using a so-called base material composition.3 Speciﬁc
calibration equations of identiﬁcation of dedicated anatomical
entities consisting of either one of thematerials is not required.
As shown by Pietrobelli et al.
4
in terms of the so-called R-value
that quantiﬁes differences in the mass absorption coefﬁcient
for a given material at different X-ray energies fatty acids and
triglycerides the ingredients of can well be separated from
non-lipid body composition materials.
From this perspective, lean and fat mass as measured by
DXA are clearly deﬁned, but do not necessarily agree with
anatomical entities such as the amount of adipose tissue.
As fat is a term used in many different contexts, perhaps a
different name should have been given to what is now known
as DXA fat mass. We agree that DXA lean body mass is
smaller than FFM.5 FFM is the mass of the body excluding
the chemical fat. So essential lipids are also excluded. Lean
body mass, interpreted the ‘DXA way’, is the soft lean tissue
of the body, excluding the bone minerals and the chemical
fat. However, lean body mass from a historical point of view,
does include the bone, and very closely resembles FFM (but
is not perfectly the same). What we would like to stress is
that the concept of lean body mass (of FFM for that matter)
is not very useful for muscle research. You would like to focus
on the bone-free and fat-free mass of the arms and legs, as
this measure most closely resembles the actual skeletal
muscle tissue. Apparently, a standardization of terminology
in the ﬁeld of body composition is required.
We agree with comments that lean mass and muscle
mass are two different measurements but this was clearly
outlined as a weakness of DXA in Table 1. However, as the
commentators showed themselves, the correlation was high
(r = 0.94),6 and lean was almost the sum of muscle, skin, and
viscera. In the appendicular skeleton, there is no viscera, thus
only the difference in the lean composition, i.e. the variation
of relative amounts of water, protein, and glycogen remains.
With regard to estimations of fat-free mass and (appendic-
ular) lean mass using bioelectrical impedance (BIA), we appre-
ciate the conﬁrmation that large prediction errors at the
individual level may occur which hampers the use of BIA in
clinical practice. We also showed that on a group level, dis-
crepancies might occur between lean mass predicted by BIA
and lean mass measured by DXA. We agree these discrepan-
cies should not be interpreted as BIA not being valid to assess
lean mass. We merely provided these examples to highlight
the fact that estimates of lean mass from BIA clearly differ
from those from DXA, thereby inﬂuencing the interpretation
of ﬁndings (e.g. the prevalence of sarcopenia and the compar-
ison of data obtained with different methods).
Given the high degree of DXA standardization, excellent
precision, the high correlation of DXA lean mass with muscle
mass and muscle volume, currently DXA seems to be the best
reference technique, in particular for appendicular muscle
measurements. This does not imply that DXA will be the
gold standard for the diagnosis of sarcopenia, which requires
a functional component in addition to appendicular muscle
mass assessments. It also calls for further efforts to develop
anthropometric standards representing the wide range of body
compositions encountered in the clinical routine in order to
validate the accuracy of methods, such as DXA and BIA. At this
stage, the scientiﬁc evidence derived from the published liter-
ature seems to support the conclusions of the original article.
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